News

The acquired company operates in the areas of engineering and manufacturing of equipment for the physical testing of pharmaceutical dosage forms, including tablets, capsules, ampules, and other solid

Using screening and structure-based medicinal chemistry optimization, the company identified potent and selective Usp14 inhibitors and expects to advance them as therapeutic candidates into clinical studies in 2015.

The approval follows positive data from MCL-001 phase II, multi-center study of lenalidomide, which was conducted in 134 MCL patients previously treated with rituximab, cyclophosphamide, an anthracycline (or

Following the receipt of regulatory approvals in the various countries in Latin America, Tecnofarma will distribute the US FDA approved product for the treatment of metastatic castration resistant

The new centre has the flexibility to adapt deal structures that go with early-stage needs and opportunities, and is expected to support nearly 20,000 jobs either directly or

Under the collaboration, Janssen will make an upfront payment and fund research activities concerning the agreement in addition to potential payments on reaching certain research milestones. The Johnson

Marketed through Renaissance’s division Prestium Pharma, the products of GSK and Stiefel include Evoclin Foam, Extina Foam, Luxiq Foam, Olux Foam, Olux-E Foam, Vusion Ointment, Zovirax Capsules, Zovirax

Started in January 2012, construction cost of the new facility was nearly JPY6.4bn ($64.3m) and is expected to be fully operational in July 2013. The new facility will

Investigational recombinant analog of the human hormone leptin, Metreleptin is being assessed for the treatment of metabolic disorders coupled with inherited or acquired lipodystrophy. Bristol-Myers CV and Metabolics